Your browser doesn't support javascript.
loading
Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao'an district of Shenzhen,China.
Wang, Ziqi; Chen, Linxiang; Lu, Fangfang; Peng, Jing; Huang, Fang; Xie, Xu; Kong, Dongfeng.
Afiliação
  • Wang Z; Department of Communicable Disease Control and Prevention, Baoan District Center for Disease Control and Prevention, Shenzhen, China.
  • Chen L; Shenzhen Field Epidemiology Training Program (SZFETP), Shenzhen, China.
  • Lu F; Shenzhen Field Epidemiology Training Program (SZFETP), Shenzhen, China.
  • Peng J; Department of Immunization Planning, Luohu District Center for Disease Control and Prevention, Shenzhen, China.
  • Huang F; Shenzhen Field Epidemiology Training Program (SZFETP), Shenzhen, China.
  • Xie X; Department of Disease Control, Baoan Public Health Service Centre, Shenzhen, China.
  • Kong D; Department of Immunization Planning, Baoan District Center for Disease Control and Prevention, Shenzhen, China.
Hum Vaccin Immunother ; 20(1): 2364485, 2024 Dec 31.
Article em En | MEDLINE | ID: mdl-39053454
ABSTRACT
The objective of the study is to analyze the implementation effect of the Live Attenuated Varicella Vaccine (VarV) Vaccination Program for eligible children in Bao'an District, Shenzhen, and evaluate the vaccine effectiveness. Children's vaccination data was obtained from the Shenzhen Immunization Planning Information Management System, while varicella case data came from the China Disease Prevention and Control Information System. The Joinpoint regression method examined vaccination rate trends, and a retrospective cohort study assessed vaccine effectiveness. After program implementation, VarV vaccination rates significantly increased, surpassing provincial and national averages. Overall incidence declined 54.6% across age groups, with the largest reductions among 7- and 6-year-olds. One year post-vaccination, single-dose vaccine effectiveness was 91.1% (95% CI 79.2% to 96.2%). However, two doses remained 91.4% effective(95% CI 89.1% to 93.2%) after 7 years. Overall, Shenzhen's VarV program achieved positive results. For children under six, routine immunization with two doses of VarV should be strengthened. Furthermore, we recommend that physicians conduct thorough inquiries to ascertain patients' vaccination history and previous varicella infections. This will enable doctors to provide tailored vaccination recommendations based on comprehensive, practical evaluations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Atenuadas / Varicela / Vacinação / Programas de Imunização / Vacina contra Varicela Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Hum Vaccin Immunother / Hum. vaccin. immunother. (Online) / Human vaccines & immunotherapeutics (Online) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Atenuadas / Varicela / Vacinação / Programas de Imunização / Vacina contra Varicela Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Hum Vaccin Immunother / Hum. vaccin. immunother. (Online) / Human vaccines & immunotherapeutics (Online) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos